rGM-CSF

recombinant granulocyte-macrophage colony-stimulating factor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rGM-CSF, covering 2021-11-03 to 2021-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma [Phase 3]

See pricing